Latest News about MRNA
Recent news which mentions MRNA
Corona Doom 2.0: Carter Worth Warns That Vaccine-Maker Moderna May Have Further To Fall. What To Do If You're Long.
Today 11:38 EDT
From Benzinga
From MarketWatch
2 COVID Stocks I'd Consider Instead of Moderna
Today 10:00 EDT
From Motley Fool
From Benzinga
Why the FDA Isn't Thrilled About Moderna's COVID-19 Booster
Today 6:05 EDT
From Motley Fool
A Peek Into The Markets: US Stock Futures Down Ahead Of Earnings, Jobless Claims Data
Today 6:00 EDT
From Benzinga
Baillie Gifford Trimmed Positions In Alibaba, Tesla, Nio, Moderna In Q3, Here's What It Bought Instead
Today 4:43 EDT
From Benzinga
From Benzinga
People who got J&J’s COVID-19 shot will soon be able to get a booster. Which one should they get?
October 20, 2021
From MarketWatch
3 Under-the-Radar COVID Stocks
October 20, 2021
From Motley Fool
Here's Why Moderna's Growth May Be Just Getting Started
October 20, 2021
From Motley Fool
3 Biotech Stocks That Are Ridiculously Overpriced
October 20, 2021
From Motley Fool
Recent Weakness May Mean Opportunity With Moderna Stock
October 19, 2021
Tickers
MRNA
From InvestorPlace
From Benzinga
Is Now a Good Time to Buy Ocugen?
October 19, 2021
From Motley Fool
U.S. COVID-19 death toll tops 726,000 amid report FDA to allow people mix and match vaccine booster shots
October 19, 2021
From MarketWatch
FDA May Allow 'Mix and Match' Regime For COVID-19 Booster Shots: NYT
October 19, 2021
From Benzinga
From Motley Fool
Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna
October 19, 2021
From Motley Fool
FDA may soon approve mixing and matching COVID booster shots
October 18, 2021
From MarketWatch
Decision On Moderna's COVID-19 Vaccine For Adolescents Delayed - What You Need To Know
October 18, 2021
From Benzinga
Allison Williams leaves ESPN over vaccine mandate: ‘I cannot put a paycheck over principle’
October 18, 2021
From MarketWatch
Why Moderna Shares Are Rebounding From Friday's Losses
October 18, 2021
From Benzinga
U.S. may soon authorize boosters for all 3 in-use vaccines, as experts renew plea for unvaccinated to get their shots
October 18, 2021
From MarketWatch
Is Moderna a Good Healthcare Stock to Buy Now?
October 18, 2021
From Motley Fool
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
Can Pfizer and GlaxoSmithKline Beat Johnson & Johnson's RSV Vaccine?
October 17, 2021
From Motley Fool
2 Biotech Stocks Poised for Jaw-Dropping Growth
October 17, 2021
From Motley Fool
Will New COVID-19 Vaccines Be Needed in 2022?
October 17, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.